Development and validation of Gaucher disease type 1 (GD1)-specific patient-reported outcome measures (PROMs) for clinical monitoring and for clinical trials

被引：0
|
作者：
Deborah Elstein
Nadia Belmatoug
Patrick Deegan
Özlem Göker-Alpan
Derralynn A. Hughes
Ida Vanessa D. Schwartz
Neal Weinreb
Nicola Bonner
Charlotte Panter
Donna Fountain
Andrew Lenny
Louise Longworth
Rachael Miller
Koonal Shah
Jörn Schenk
Rohini Sen
Ari Zimran
机构：
[1] Takeda Pharmaceuticals International AG,Assistance
[2] Université de Paris,Publique Hôpitaux de Paris Nord
[3] Cambridge University Hospitals,Lysosomal Disorders Unit
[4] O&O Alpan LLC,Lysosomal Disorders Unit and Center for Clinical Trials
[5] Royal Free London NHS Foundation Trust,Medical Genetics Service
[6] UFRGS, HCPA, Genetics Department
[7] University of Miami Miller School of Medicine,Gaucher Unit
[8] Adelphi Values,undefined
[9] PHMR,undefined
[10] Takeda Pharmaceuticals Company Ltd,undefined
[11] Shaare Zedek Medical Center,undefined
[12] Hebrew University-Hadassah Medical School,undefined
来源：
Orphanet Journal of Rare Diseases | / 17卷
关键词：
Patient-reported outcomes; PROM; Gaucher disease; Lysosomal storage disorder; Questionnaire; Content validation; Psychometric validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials
    Coleman, Robert L.
    Beck, J. Thaddeus
    Baranda, Joaquina C.
    Jacobs, Ira
    Smoyer, Karen E.
    Lee, Lauren J.
    Askerova, Zemfira
    McGinnis, Justin
    Ganti, Apar Kishor
    ONCOLOGY, 2021, : 444 - 453
  • [42] Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations
    Turk, Dennis C.
    Dworkin, Robert H.
    Burke, Laurie B.
    Gershon, Richard
    Rothman, Margaret
    Scott, Jane
    Allen, Robert R.
    Atkinson, J. Hampton
    Chandler, Julie
    Cleeland, Charles
    Cowan, Penny
    Dimitrova, Rozalina
    Dionne, Raymond
    Farrar, John T.
    Haythornthwaite, Jennifer A.
    Hertz, Sharon
    Jadad, Alejandro R.
    Jensen, Mark P.
    Kellstein, David
    Kerns, Robert D.
    Manning, Donald C.
    Martin, Susan
    Max, Mitchell B.
    McDermott, Michael P.
    McGrath, Patrick
    Moulin, Dwight E.
    Nurmikko, Turo
    Quessy, Steve
    Raja, Srinivasa
    Rappaport, Bob A.
    Rauschkolb, Christine
    Robinson, James P.
    Royal, Mike A.
    Simon, Lee
    Stauffer, Joseph W.
    Stucki, Gerold
    Tollett, Jane
    von Stein, Thorsten
    Wallace, Mark S.
    Wernicke, Joachim
    White, Richard E.
    Williams, Amanda C.
    Witter, James
    Wyrwich, Kathleen W.
    PAIN, 2006, 125 (03) : 208 - 215
  • [43] Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials
    Saketkoo, Lesley Ann
    Scholand, Mary Beth
    Lammi, Matthew R.
    Russell, Anne-Marie
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (2_SUPPL) : 48 - 60
  • [44] Using patient-reported outcome measures in clinical trials: perspectives for and against a modular approach
    Ng, Carrie-Anne
    Roydhouse, Jessica
    Luckett, Tim
    Lourenco, Richard De Abreu
    Mulhern, Brendan
    MEDICAL JOURNAL OF AUSTRALIA, 2025,
  • [45] Importance of Patient-Reported Outcome Measures on Clinical Practice in Patients With Kidney Disease
    Frazier, Rebecca
    Peipert, John Devin
    KIDNEY MEDICINE, 2021, 3 (04) : 473 - 474
  • [46] COMPARISON OF CLINICAL AND PATIENT-REPORTED OUTCOME MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Yang, Y.
    Pickard, A. S.
    Lee, T.
    VALUE IN HEALTH, 2011, 14 (03) : A142 - A142
  • [47] Patient-reported outcome measures in type 1 diabetes outpatient care
    Rochate, J.
    do Vale, S.
    HIPPOKRATIA, 2024, 28 (01) : 17 - 21
  • [48] Use of patient-reported outcome measures (PROMs) in clinical diabetes consultations: the DiaPROM randomised controlled pilot trial
    Hernar, Ingvild
    Graue, Marit
    Richards, David A.
    Strandberg, Ragnhild B.
    Nilsen, Roy Miodini
    Rekdal, Magne
    Lovaas, Karianne Fjeld
    Madsen, Tone, V
    Tell, Grethe S.
    Haugstvedt, Anne
    BMJ OPEN, 2021, 11 (04):
  • [49] Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges
    Lefkovits, Yael R.
    Heriot, Natalie
    Sporik, Alice
    Perera, Sharnel
    Friedlander, Michael
    Dixon, Cyril
    Cohen, Paul A.
    Lee, Yeh Chen
    Hyde, Simon
    Richardson, Gary
    Webb, Penelope
    Rome, Robert
    King, Madeleine
    Zalcberg, John
    Schofield, Penelope
    BMC HEALTH SERVICES RESEARCH, 2024, 24 (01)
  • [50] Barriers and enablers to implementing patient-reported outcome measures (PROMs) in clinical settings: A meta-review of reviews
    Rutherford, Claudia
    Campbell, Rachel
    Mueller, Fabiola
    Roberts, Natasha
    Tinsley, Melissa
    Speerin, Robyn
    Soars, Linda
    Butcher, Anna
    King, Madeleine T.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 148 - 148
12345